SM, A., KA, S., CJ, D., CJ, H., D, T., J, H., . . . DY, K. (2011). Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs. Dove Medical Press.
Chicago Style (17th ed.) CitationSM, Axiak, Selting KA, Decedue CJ, Henry CJ, Tate D, Howell J, Bilof KJ, and Kim DY. Phase I Dose Escalation Safety Study of Nanoparticulate Paclitaxel (CTI 52010) in Normal Dogs. Dove Medical Press, 2011.
MLA (8th ed.) CitationSM, Axiak, et al. Phase I Dose Escalation Safety Study of Nanoparticulate Paclitaxel (CTI 52010) in Normal Dogs. Dove Medical Press, 2011.
Warning: These citations may not always be 100% accurate.